Clinical Trial Update: Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies

View source ↗

Summary

A clinical trial exploring cellular immune responses in triple-negative breast cancer using high-throughput immunogenetic studies is currently enrolling by invi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Institute of Applied Biosciences | Conditions: Triple Negative Breast Cancer | Status: ENROLLING_BY_INVITATION